Evidence map›Paper›PMID 38974917›Full record

ArticleFrontiers in psychiatry2024

The methods and baseline characteristics of a multi-site randomized controlled trial evaluating mindfulness-based relapse prevention in conjunction with peer support to improve adherence to medications for opioid use disorders.

Mercy Ngosa Mumba, George Tongi Mugoya, Rebecca S Allen, Andrea L Glenn, Joshua Richman, Anchal Ghera, Austin Butler, Blossom Rogers, Teresa Ann Granger, Lori L Davis

Abstract read
In one paragraph

Article in Frontiers in psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mercy Ngosa MumbaCapstone College of Nursing, University of Alabama, Tuscaloosa, AL, United States.
George Tongi MugoyaTuscaloosa VA Medical Center, Tuscaloosa, AL, United States.
Rebecca S AllenDepartment of Psychology, University of Alabama, Tuscaloosa, AL, United States.
Andrea L GlennDepartment of Psychology, University of Alabama, Tuscaloosa, AL, United States.
Joshua RichmanDepartment of Surgery, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, United States.
Anchal GheraTuscaloosa VA Medical Center, Tuscaloosa, AL, United States.
Austin ButlerCapstone College of Nursing, University of Alabama, Tuscaloosa, AL, United States.
Blossom RogersCapstone College of Nursing, University of Alabama, Tuscaloosa, AL, United States.
Teresa Ann GrangerTuscaloosa VA Medical Center, Tuscaloosa, AL, United States.
Lori L DavisTuscaloosa VA Medical Center, Tuscaloosa, AL, United States.

Funding

A Mindfulness and Peer Mentoring Program to Improve Adherence to Medication Assisted Treatment for Opioid Use DisordersR33AT010802 · NCCIH · UNIVERSITY OF ALABAMA IN TUSCALOOSA · PI MUMBA, MERCY N · 2021 to 2023
$1.9M
NCCIH NIH HHS R33 AT010802
6 · The paper itself

Abstract

Introduction: Medications for opioid use disorders (MOUD) remain the gold standard for treating OUD, but treatment initiation and adherence remain challenging. Exclusive utilization of pharmacotherapy as a treatment modality for OUD is sub-optimal, and a combination of psychotherapies and pharmacotherapies is recommended. General trends indicate the benefits of peer mentoring and MBRP separately. Therefore, we hypothesize that the combined effect of MBRP and Peer mentoring will produce synergistic improvements in MOUD adherence compared to an enhanced twelve-step facilitation (TSF). Methods: This paper describes the methods and baseline characteristics of a multi-site randomized controlled trial evaluating the effectiveness of a combination of MBRP and peer support (MiMP) compared to an enhanced TSF in improving adherence to MOUD. Both MiMP and TSF are 12-week manualized protocols that utilize licensed therapists. The interventions are delivered in weekly group sessions that last about 75-90 minutes per session. The primary outcome is MOUD adherence. Secondary and exploratory outcomes include relapse, cravings, depression, anxiety, stress, quality of life, and pain catastrophizing. Results: The participants' ages ranged from 21 years to 77 years, with a mean age of 44.5 (SD ± 11.5 years). There was an almost equal distribution of gender and place of residence. Overall, 51.9% (n=54) of participants identified as female and 48.1% (n=50) were male. Similarly, 51.9% (n=54) of participants resided in urban areas, while 48.1% (n=50) resided in rural areas. Participants identified as either black or white, with over three-quarters identifying as white (77.9%, n= 81) and 22.1% (n= 23) as black. Most participants randomized to the 12-step facilitation group were white (93.1%). Relationships and employment status were well distributed between categories. Over half of the participants reported some college or higher education. Over 90% of the participants made less than $75,000 per year. Some participants indicated that they had both public and private health insurance. Discussion and conclusion: This study is innovative in several ways including combining MBRP and peer support, addressing comorbid mental health issues among individuals with OUD, utilizing manualized protocols, and evaluating of both physiological and self-reported measures in assessing cortisol reactivity as a predictor of relapse and treatment outcomes.

Indexed as

buprenorphinemindfulness based relapse preventionMOUDopioid use disorderrelapsesubstance use disordertwelve-step facilitation

Identifiers

PMID38974917
PMCPMC11224476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.